{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:35:06Z","timestamp":1773873306603,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-025-06548-0","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:28:42Z","timestamp":1760948922000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical use and safety profile of intravenous linezolid in hospitalised children: A retrospective cohort experience"],"prefix":"10.1007","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7121-3810","authenticated-orcid":false,"given":"\u00d6mer","family":"G\u00fcne\u015f","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5691-2461","authenticated-orcid":false,"given":"Asl\u0131nur","family":"\u00d6zkaya-Parlakay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3446-7034","authenticated-orcid":false,"given":"Ahmet Yasin","family":"G\u00fcney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0677-7606","authenticated-orcid":false,"given":"Fatih","family":"\u00dc\u00e7karde\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3111-6888","authenticated-orcid":false,"given":"Zehra Nihan","family":"Co\u015fkun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9891-6655","authenticated-orcid":false,"given":"Selin","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7245-2028","authenticated-orcid":false,"given":"Aysun","family":"Yah\u015fi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8342-3786","authenticated-orcid":false,"given":"Seval","family":"\u00d6zen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2434-4134","authenticated-orcid":false,"given":"Tu\u011fba","family":"Erat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2538-2872","authenticated-orcid":false,"given":"Saliha","family":"Kan\u0131k-Y\u00fcksek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0839-1301","authenticated-orcid":false,"given":"Belgin","family":"G\u00fclhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1423-4348","authenticated-orcid":false,"given":"G\u00fcls\u00fcm \u0130clal","family":"Bayhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"issue":"24","key":"6548_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000034059","volume":"102","author":"S Yang","year":"2023","unstructured":"Yang S, Guo W, Chen M, Hu J, Feng N, Ju M, Qian Y (2023) Prevalence and risk factors for severe linezolid-associated thrombocytopenia in pediatric patients: an analysis of a public database. Medicine (Baltimore) 102(24):e34059. https:\/\/doi.org\/10.1097\/MD.0000000000034059","journal-title":"Medicine (Baltimore)"},{"key":"6548_CR2","doi-asserted-by":"publisher","unstructured":"Lin SK, Mulieri KM, Ishmael FT (2017) Characterisation of vancomycin reactions and linezolid utilization in the pediatric population. J Allergy Clin Immunol Pract 5(3):750\u2013756.  https:\/\/doi.org\/10.1016\/j.jaip.2016.12.022","DOI":"10.1016\/j.jaip.2016.12.022"},{"issue":"3","key":"6548_CR3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jped.2023.08.011","volume":"100","author":"BR Porchera","year":"2024","unstructured":"Porchera BR, da Silva CM, Miranda RP, Gomes ARQ, Fernandes PHDS, de Menezes CGO, Laurindo PDSODC, Dolabela MF, Br\u00edgido HPC (2024) Linezolid and vancomycin for nosocomial infections in pediatric patients: a systematic review. J Pediatr (Rio J) 100(3):242\u2013249. https:\/\/doi.org\/10.1016\/j.jped.2023.08.011","journal-title":"J Pediatr (Rio J)"},{"issue":"4","key":"6548_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12040697","volume":"12","author":"H Kawasuji","year":"2023","unstructured":"Kawasuji H, Nagaoka K, Tsuji Y, Kimoto K, Takegoshi Y, Kaneda M, Murai Y, Karaushi H, Mitsutake K, Yamamoto Y (2023) Effectiveness and safety of linezolid versus vancomycin, teicoplanin, or daptomycin against methicillin-resistant Staphylococcus aureus bacteremia: a systematic review and meta-analysis. Antibiotics 12(4):697. https:\/\/doi.org\/10.3390\/antibiotics12040697","journal-title":"Antibiotics"},{"issue":"Suppl 4","key":"6548_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/1469-0691.12463","volume":"20","author":"M Bassetti","year":"2014","unstructured":"Bassetti M, Baguneid M, Bouza E, Dryden M, Nathwani D, Wilcox M (2014) European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid. Clin Microbiol Infect 20(Suppl 4):3\u201318. https:\/\/doi.org\/10.1111\/1469-0691.12463","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"6548_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s40360-022-00628-9","volume":"23","author":"X Liu","year":"2022","unstructured":"Liu X, Aoki M, Osa S, Ito C, Saiki R, Nagai T, Enoki Y, Taguchi K, Matsumoto K (2022) Safety of linezolid in patients with decreased renal function and trough monitoring: a systematic review and meta-analysis. BMC Pharmacol Toxicol 23(1):89. https:\/\/doi.org\/10.1186\/s40360-022-00628-9","journal-title":"BMC Pharmacol Toxicol"},{"issue":"5","key":"6548_CR7","doi-asserted-by":"publisher","first-page":"470","DOI":"10.5546\/aap.2017.eng.470","volume":"115","author":"N Bayram","year":"2017","unstructured":"Bayram N, D\u00fczg\u00f6l M, Kara A, \u00d6zdemir FM, Devrim \u0130 (2017) Linezolid-related adverse effects in clinical practice in children. Arch Argent Pediatr 115(5):470\u2013475. https:\/\/doi.org\/10.5546\/aap.2017.eng.470","journal-title":"Arch Argent Pediatr"},{"issue":"2","key":"6548_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4212\/cjhp.v72i2.2883","volume":"72","author":"N Giunio-Zorkin","year":"2019","unstructured":"Giunio-Zorkin N, Brown G (2019) Real-life frequency of new-onset thrombocytopenia during linezolid treatment. Can J Hosp Pharm. 72(2):133\u2013138","journal-title":"Can J Hosp Pharm."},{"issue":"10","key":"6548_CR9","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3855\/jidc.10859","volume":"13","author":"E Kaya K\u0131l\u0131\u00e7","year":"2019","unstructured":"Kaya K\u0131l\u0131\u00e7 E, Bulut C, S\u00f6nmezer M\u00c7, Ozel \u00d6, Ataman Hatipo\u011flu \u00c7, Tuncer Ertem G, T\u00fclek N, K\u0131n\u0131kl\u0131 S (2019) Risk factors for linezolid-associated thrombocytopenia and negative effect of carbapenem combination. J Infect Dev Ctries 13(10):886\u2013891. https:\/\/doi.org\/10.3855\/jidc.10859","journal-title":"J Infect Dev Ctries"},{"issue":"8","key":"6548_CR10","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.jiac.2021.03.003","volume":"27","author":"H Kato","year":"2021","unstructured":"Kato H, Hagihara M, Asai N, Koizumi Y, Yamagishi Y, Mikamo H (2021) A systematic review and meta-analysis of myelosuppression in pediatric patients treated with linezolid for Gram-positive bacterial infections. J Infect Chemother 27(8):1143\u20131150. https:\/\/doi.org\/10.1016\/j.jiac.2021.03.003","journal-title":"J Infect Chemother"},{"key":"6548_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.926711","volume":"13","author":"BN Huo","year":"2022","unstructured":"Huo BN, Wu YE, Shu L, Zhang RQ, Xiao JW, Li QB, Zhao W, Jia YT, Song L (2022) Relationship between linezolid exposure and the typical clinical laboratory safety and bacterial clearance in Chinese pediatric patients. Front Pharmacol 13:926711. https:\/\/doi.org\/10.3389\/fphar.2022.926711","journal-title":"Front Pharmacol"},{"key":"6548_CR12","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2024) Breakpoint tables for interpretation of MICs and zone diameters. Version 14.0.\u00a0EUCAST,\u00a0Basel. Available from: https:\/\/www.eucast.org\/clinical_breakpoints\/. Accessed 30 Dec 2024"},{"issue":"4","key":"6548_CR13","doi-asserted-by":"publisher","first-page":"e1236","DOI":"10.1002\/prp2.1236","volume":"12","author":"L Shu","year":"2024","unstructured":"Shu L, Huo BN, Yin NG, Xie HJ, Erbu A, Ai ML, Jia YT, Song L (2024) Clinical drug interactions between linezolid and other antibiotics: for adverse drug event monitoring. Pharmacol Res Perspect 12(4):e1236. https:\/\/doi.org\/10.1002\/prp2.1236","journal-title":"Pharmacol Res Perspect"},{"issue":"10","key":"6548_CR14","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1093\/jac\/dkr285","volume":"66","author":"S Garazzino","year":"2011","unstructured":"Garazzino S, Krzysztofiak A, Esposito S, Castagnola E, Plebani A, Galli L, Cellini M, Lipreri R, Scolfaro C, Bertaina C, Calitri C, Bozzola E, Lancella L, Quondamcarlo A, Bosis S, Pugni L, Losurdo G, Soresina A, De Gaudio M, Mariotti I, Mancini L, Gabiano C, Tovo PA (2011) Use of linezolid in infants and children: a retrospective multicentre study of the Italian Society for Paediatric Infectious Diseases. J Antimicrob Chemother 66(10):2393\u20132397. https:\/\/doi.org\/10.1093\/jac\/dkr285","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"6548_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s12519-022-00650-1","volume":"19","author":"Y Shi","year":"2023","unstructured":"Shi Y, Wu HL, Wu YH, Li S, Zhang LY, Xu SS, Huang HY, Zhang CH, Yu XB, Cai K, Zhang J, Huang LS (2023) Safety and clinical efficacy of linezolid in children: a systematic review and meta-analysis. World J Pediatr 19(2):129\u2013138. https:\/\/doi.org\/10.1007\/s12519-022-00650-1","journal-title":"World J Pediatr"},{"issue":"8","key":"6548_CR16","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jiac.2016.05.003","volume":"22","author":"Y Hanai","year":"2016","unstructured":"Hanai Y, Matsuo K, Ogawa M, Higashi A, Kimura I, Hirayama S, Kosugi T, Nishizawa K, Yoshio T (2016) A retrospective study of the risk factors for linezolid-induced thrombocytopenia and anemia. J Infect Chemother 22(8):536\u2013542. https:\/\/doi.org\/10.1016\/j.jiac.2016.05.003","journal-title":"J Infect Chemother"},{"key":"6548_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1292828","volume":"15","author":"X Zhao","year":"2024","unstructured":"Zhao X, Peng Q, Hu D, Li W, Ji Q, Dong Q, Huang L, Piao M, Ding Y, Wang J (2024) Prediction of risk factors for linezolid-induced thrombocytopenia based on neural network model. Front Pharmacol 15:1292828. https:\/\/doi.org\/10.3389\/fphar.2024.1292828","journal-title":"Front Pharmacol"},{"issue":"3","key":"6548_CR18","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1093\/jpids\/piu035","volume":"4","author":"SJ Jones","year":"2015","unstructured":"Jones SJ, Nichols KR, DeYoung HL, Cox EG, Knoderer CA (2015) Linezolid-associated thrombocytopenia in children with renal \u0131mpairment. J Pediatric Infect Dis Soc 4(3):272\u2013275. https:\/\/doi.org\/10.1093\/jpids\/piu035","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"1","key":"6548_CR19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/jcpt.12762","volume":"44","author":"HS Kim","year":"2019","unstructured":"Kim HS, Lee E, Cho YJ, Lee YJ, Rhie SJ (2019) Linezolid-induced thrombocytopenia increases mortality risk in intensive care unit patients, a 10 year retrospective study. J Clin Pharm Ther 44(1):84\u201390. https:\/\/doi.org\/10.1111\/jcpt.12762","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"6548_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0286088","volume":"18","author":"H Tatsumi","year":"2023","unstructured":"Tatsumi H, Akatsuka M, Kuroda H, Kazuma S, Suzuki S, Masuda Y (2023) Effect of linezolid on platelet count in critically ill patients with thrombocytopenia. PLoS ONE 18(6):e0286088. https:\/\/doi.org\/10.1371\/journal.pone.0286088","journal-title":"PLoS ONE"},{"issue":"2","key":"6548_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/bcpt.13123","volume":"124","author":"GW Choi","year":"2019","unstructured":"Choi GW, Lee JY, Chang MJ, Kim YK, Cho Y, Yu YM, Lee E (2019) Risk factors for linezolid-induced thrombocytopenia in patients without haemato-oncologic diseases. Basic Clin Pharmacol Toxicol 124(2):228\u2013234. https:\/\/doi.org\/10.1111\/bcpt.13123","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"11","key":"6548_CR22","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s00228-024-03740-3","volume":"80","author":"M Abouelkheir","year":"2024","unstructured":"Abouelkheir M, Aldawsari MR, Ghonem L, Almomen A, Alsarhani E, Alsubaie S, Alqahtani S, Kurdee Z, Alsultan A (2024) Evaluation of pharmacokinetic target attainment and hematological toxicity of linezolid in pediatric patients. Eur J Clin Pharmacol 80(11):1807\u20131817. https:\/\/doi.org\/10.1007\/s00228-024-03740-3","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"6548_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.curtheres.2012.07.002","volume":"73","author":"C Chen","year":"2012","unstructured":"Chen C, Guo DH, Cao X, Cai Y, Xu Y, Zhu M, Ma L (2012) Risk factors for thrombocytopenia in adult Chinese patients receiving linezolid therapy. Curr Ther Res Clin Exp 73(6):195\u2013206. https:\/\/doi.org\/10.1016\/j.curtheres.2012.07.002","journal-title":"Curr Ther Res Clin Exp"},{"issue":"2","key":"6548_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4046\/trd.2021.0122","volume":"85","author":"A Oehadian","year":"2022","unstructured":"Oehadian A, Santoso P, Menzies D, Ruslami R (2022) Concise clinical review of hematologic toxicity of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis: role of mitochondria. Tuberculosis Respir Dis 85(2):111\u2013121. https:\/\/doi.org\/10.4046\/trd.2021.0122","journal-title":"Tuberculosis Respir Dis"},{"issue":"4","key":"6548_CR25","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ijantimicag.2014.06.017","volume":"44","author":"A Ozkaya-Parlakay","year":"2014","unstructured":"Ozkaya-Parlakay A, Kara A, Celik M, Ozsurekci Y, Karadag Oncel E, Ceyhan M, Cengiz AB (2014) Early lactic acidosis associated with linezolid therapy in paediatric patients. Int J Antimicrob Agents 44(4):334\u2013336. https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.06.017","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"6548_CR26","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s10096-011-1461-1","volume":"31","author":"A Simon","year":"2012","unstructured":"Simon A, M\u00fcllenborn E, Prelog M, Schenk W, Holzapfel J, Ebinger F, Klabunde-Cherwon A, Faber J, Groll AH, Masjosthusmann K, Dohna-Schwake C, Beutel K, Dirkwinkel E, Lehrnbecher T, Ammann RA, M\u00fcller A (2012) Use of linezolid in neonatal and pediatric inpatient facilities\u2013results of a retrospective multicenter survey. Eur J Clin Microbiol Infect Dis 31(7):1435\u20131442. https:\/\/doi.org\/10.1007\/s10096-011-1461-1","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"6548_CR27","doi-asserted-by":"publisher","first-page":"2282351","DOI":"10.1155\/2022\/2282351","volume":"2022","author":"J Xie","year":"2022","unstructured":"Xie J, Chen H, Li Y, Liu C, Zheng X, Feng S, Wang H (2022) Identifying and targeting prediction of the PI3K-AKT signaling pathway in drug-\u0131nduced thrombocytopenia in \u0131nfected patients receiving linezolid therapy: a network pharmacology-based analysis. J Healthc Eng 2022:2282351. https:\/\/doi.org\/10.1155\/2022\/2282351","journal-title":"J Healthc Eng"},{"issue":"9","key":"6548_CR28","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1097\/INF.0b013e3182186035","volume":"30","author":"E Su","year":"2011","unstructured":"Su E, Crowley K, Carcillo JA, Michaels MG (2011) Linezolid and lactic acidosis: a role for lactate monitoring with long-term linezolid use in children. Pediatr Infect Dis J 30(9):804\u2013806. https:\/\/doi.org\/10.1097\/INF.0b013e3182186035","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"6548_CR29","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.jiac.2020.07.018","volume":"26","author":"V Smolka","year":"2020","unstructured":"Smolka V, Rohanova M, Ludikova B, Novak Z, Zapalka M, Pospisilova D, Volejnikova J (2020) Severe linezolid-induced lactic acidosis in a child with acute lymphoblastic leukemia: a case report. J Infect Chemother 26(12):1316\u20131318. https:\/\/doi.org\/10.1016\/j.jiac.2020.07.018","journal-title":"J Infect Chemother"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06548-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-025-06548-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06548-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T07:35:22Z","timestamp":1762846522000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-025-06548-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":29,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["6548"],"URL":"https:\/\/doi.org\/10.1007\/s00431-025-06548-0","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and the principles of Good Clinical Practice. The study protocol was approved by the Clinical Research Ethics Committee of Ankara City Hospital (approval date: January 18, 2023; approval no: E2-23\u20133183).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"705"}}